Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

NCT03180567 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT03180567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03180567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Unknown status
Start date
June 6, 2017
Completion date
December 31, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombosis